S&P 500 7,816 +1.37% Nasdaq 26,873 +1.99% Dow Jones 53,981 +0.18% FTSE 100 10,781 -0.80% DAX 26,363 +0.85% Nikkei 225 68,309 +4.00% Hang Seng 25,397 -0.52% WTI Crude 80.67 -1.78% Gold 4,431 +1.59% US 10-Year Treasury Yield 4.613 -1.01% S&P 500 7,816 +1.37% Nasdaq 26,873 +1.99% Dow Jones 53,981 +0.18% FTSE 100 10,781 -0.80% DAX 26,363 +0.85% Nikkei 225 68,309 +4.00% Hang Seng 25,397 -0.52% WTI Crude 80.67 -1.78% Gold 4,431 +1.59% US 10-Year Treasury Yield 4.613 -1.01%

LATEST

Google makes costly bet Apple proved can work●Bitcoin continues ranging as crowded longs meet soft inflation, the quietest tape since 2019: analysts●Resurgens Technology Partners invests in quality compliance platform Qarma●Kalshi in talks with Sequoia, Wellington for $750 million fund raise at $40 billion valuation●Beauty and cosmetics retailer Douglas’ stores “under review” after Q3 loss●Databricks wraps $5 billion funding round at $190 billion valuation●Customs rejects smuggling, revenue leakage claims, defends digital reforms●Ether.fi adds tokenized stocks, metals and Aave-powered portfolio loans in latest ‘neobank’ expansion●Google makes costly bet Apple proved can work●Bitcoin continues ranging as crowded longs meet soft inflation, the quietest tape since 2019: analysts●Resurgens Technology Partners invests in quality compliance platform Qarma●Kalshi in talks with Sequoia, Wellington for $750 million fund raise at $40 billion valuation●Beauty and cosmetics retailer Douglas’ stores “under review” after Q3 loss●Databricks wraps $5 billion funding round at $190 billion valuation●Customs rejects smuggling, revenue leakage claims, defends digital reforms●Ether.fi adds tokenized stocks, metals and Aave-powered portfolio loans in latest ‘neobank’ expansion●

Markets

Lilly gains access to market that could add millions of customers

TST (Full) - (Official Feed) · 2h ago · 🇬🇧 United Kingdom

Lilly gains access to market that could add millions of customers

Eli Lilly (LLY) has spent 2026 defending its lead in the weight-loss drug market, mostly with injections. That approach is changing. On Aug. 10, Britain's medicines regulator cleared Lilly's new daily pill for both weight management and type 2 diabetes. It was the first approval the drug received ...

Read the full story at TST (Full) - (Official Feed) →

More Markets

Google makes costly bet Apple proved can work

TST (Full) - (Official Feed) · 21m ago

Blackstone marked down its most popular griddles and accessories to as low as $15

TST (Full) - (Official Feed) · 38m ago

Intel's $20 billion stock sale has surprising upside

TST (Full) - (Official Feed) · 1h ago

A luxurious Canadian hotel brand is coming to snowy Japan

TST (Full) - (Official Feed) · 1h ago